Browsing by Author "Bongertz, Vera"
Now showing items 21-40 of 44
-
Identification of human immunodeficiency virus type 1 envelope genes recombinant between subtypes B and F in two epidemiologically linked individuals from Brazil.
Sabino, Ester Cerdeira et al. | Date Issued: 1994 -
Immune activation and antibody responses in non-progressing elite controller individuals infected with HIV-1
Bello, Gonzalo et al. | Date Issued: 2009 -
Immunoreactivity of Brazilian HIV isolates with different V3 motifs.
Hendry, R Michael et al. | Date Issued: 1996 -
International Network for Comparison of HIV Neutralization Assays: The NeutNet Report
Fenyö, Eva Maria et al. | Date Issued: 2009 -
International Network for Comparison of HIV Neutralization Assays: The NeutNet Report II
Bongertz, Vera et al. | Date Issued: 2012 -
Is human immunodeficiency virus/acquired immunodeficiency syndrome decreasing among Brazilian injection drug users? Recent findings and how to interpret them
Bastos, Francisco Inácio Pinkusfeld Monteiro et al. | Date Issued: 2005We briefly review findings from Brazilian settings where the human immunodeficiency virus/acquired immunodeficiency syndrome (HIV/AIDS) epidemic among injection drug users (IDUs) seems to be decreasing, highlighting recent ... -
Molecular epidemiology of HIV in Brazil: polymorphism of the antigenically distinct HIV-1B subtype strains
Morgado, Mariza Gonçalves et al. | Date Issued: 1998 -
Molecular epidemiology of HIV-1 in Brazil: high prevalence of HIV-1 subtype B and identification of an HIV-1 subtype D infection in the city of Rio de Janeiro, Brazil
Morgado, Mariza Gonçalves et al. | Date Issued: 1998 -
A nationwide effort to sistematically monitor HIV-1 diversity in Brazil: preliminary results. Brazilian Network for the HIV-1 Isolation and Characterization
Castro Filho, Bernardo Galvão et al. | Date Issued: 1996 -
Neutralization of primary HIV-1 isolated from individuals residing in Rio de Janeiro
Bongertz, Vera et al. | Date Issued: 1996 -
Neutralization susceptibility of B subtype variant B" primary HIV-1 isolates. The HEC/FIOCRUZ AIDS Clinical Research Group
Bongertz, Vera et al. | Date Issued: 1998 -
Polymorphism of the predictive antigenic sites on the V3 loop of Brazilian HIV-1 subtype B strains. HEC/FIOCRUZ AIDS Clinical Research Group.
Morgado, Mariza Gonçalves et al. | Date Issued: 1996 -
Prevalence of antibodies against an Immuno-dominat region of the HIV-1 envelope glycoprotein gp41 in sera from HIV-1 infected individuals in Brazil
Bongertz, Vera et al. | Date Issued: 1994 -
Report of the Fifth Brazilian Symposium on HIV/AIDS Research Rio de Janeiro, RJ, Brazil November 23-26, 2003
Bongertz, Vera et al. | Date Issued: 2005 -
Report of the First Brazilian Symposium on Basic Research in HIV/AIDS
Castro Filho, Bernardo Galvão et al. | Date Issued: 1996 -
Report of the second brazilian symposium on basic research in HIV/AIDS
Bongertz, Vera et al. | Date Issued: 1998 -
Retrovirus infections in a sample of injecting drug users in Rio de Janeiro City, Brazil: prevalence of HIV-1 subtypes, and co-infection with HTLV-I/II
Guimarães, Monick Lindenmeyer et al. | Date Issued: 2001Background :Retrovirus infections among injecting drug users (IDUs), a core at-risk population for both HIV-1 and HTLV-I/II infections in Brazil, were assessed within an ongoing cooperative research. Objecti e : The study ... -
Retrovirus infections in a sample of injecting drug users in Rio de Janeiro City, Brazil: prevalence of HIV-1 subtypes, and co-infection with HTLV-I/II.
Guimarães, Monick Lindenmeyer et al. | Date Issued: 2001 -
Short Communication: neutralizing antibodies in HIV-1-Infected Brazilian individuals
Almeida, Dalziza Victalina de et al. | Date Issued: 2013 -
The role of ‘‘long-term’’ and ‘‘new’’ injectors in a declining HIV/AIDS epidemic in Rio de Janeiro, Brazil
Vilas-Boas Hacker, Mariana de Andrea et al. | Date Issued: 2005Background. A substantial decline of HIV prevalence has been observed in injection drug users (IDUs) from Rio de Janeiro, in recent years. Differential characteristics and behaviors of new (injecting for <6 years) and ...